[go: up one dir, main page]

WO2002013776A2 - Procede assurant une meilleure application desodorisante sous les bras - Google Patents

Procede assurant une meilleure application desodorisante sous les bras Download PDF

Info

Publication number
WO2002013776A2
WO2002013776A2 PCT/US2001/025223 US0125223W WO0213776A2 WO 2002013776 A2 WO2002013776 A2 WO 2002013776A2 US 0125223 W US0125223 W US 0125223W WO 0213776 A2 WO0213776 A2 WO 0213776A2
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
deodorant
solvent system
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/025223
Other languages
English (en)
Other versions
WO2002013776A3 (fr
Inventor
Gerald John Guskey
John Paul Luebbe
David John Pung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to AU2001283312A priority Critical patent/AU2001283312A1/en
Publication of WO2002013776A2 publication Critical patent/WO2002013776A2/fr
Publication of WO2002013776A3 publication Critical patent/WO2002013776A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Definitions

  • the present invention relates to a method of preventing malodor of the underarm by the topical application of an aqueous gel deodorant composition comprising a skin sensate solubilized in a defined solvent system.
  • the sensate as formulated within the gel deodorant composition provides a cooling effect on the skin with minimal or no skin irritation and with minimal or no interference with the fragrance component of the deodorant composition.
  • Deodorant products generally contain a safe and effective level of perfume or other odor masking ingredients, an antimicrobial active ingredient, or a combination thereof, incorporated into a vehicle from which the active ingredients may be deposited on the skin.
  • Gel deodorant compositions have several advantages over other types of stick formulations. For example, they usually leave no more than a minimal amount of residue on the skin, and they glide easily over the skin when applied.
  • Deodorant compositions of the gel type generally incorporate three key ingredients: a material known to have deodorant efficacy, a gelling agent, and a polar solvent system. Deodorant compositions are typically aqueous compositions.
  • the gelling agents used most often in deodorant gel compositions are of the fatty acid soap type.
  • the gelling agents used in these compositions include, for instance, the sodium or potassium salts of C ⁇ 2-Q22 fatty acids.
  • These types of gel compositions most often utilize a highly polar alcohol solvent as the primary polar solvent ingredient, which is necessary to form the gel structure with the gelling agent.
  • Monohydric and dihydric alcohols, especially, propylene glycol and polyhydric alcohols such as dipropylene glycol, are typically used for this purpose.
  • compositions of various types have incorporated with them components which provide a cooling or warming sensation to skin.
  • menthol is well established as a physiological coolant, its use and effectiveness is limited in some types of compositions by its strong minty odor and its relative volatility. The high volatility of menthol limits the period of time which it can provide cooling sensation. It is believed that the molecular size of menthol as well as the manner in which it penetrates into the skin can result in skin stinging and irritation.
  • the method and composition of the present invention are directed to a deodorant composition for treating or preventing underarm malodor by topical application of an aqueous gel deodorant composition
  • an aqueous gel deodorant composition comprising: a) from about 0.01% to about 60%, by weight of a deodorant active; b) from about 0.01% to about 15%, by weight of a soap gelling agent comprising salts of Ci 2 -C 40 fatty acids; c) from about 0.01% to about 10% by weight of a fragrance; d) from about 0.2% to about 1% by weight of a skin sensate solubilized in a solvent system which comprises: i) from about 1% to about 90% by weight of the composition of a non-aqueous liquid carrier; and ii) from about 1% to about 90%, by weight of the composition of water; said solvent system having a solubility parameter of from about 9 (cal/cm3)0-5 to about 15 (cal/cm ⁇ A Also disclosed are methods of using the compositions.
  • aqueous gel deodorants can be formulated with specific skin sensates to provide an improved skin sensation with little or no skin irritation and with little or no interference with the perfume matrices of the composition.
  • the gel deodorant of the present invention provides an unmet consumer benefit by providing a cool, clean and refreshing feeling from deodorant underarm application in the absence of excessive irritation and unpleasant sensate odor.
  • compositions of the present invention are described below.
  • ambient conditions refers to surrounding conditions at about one atmosphere of pressure (1 atm), at about 50% relative humidity, and at about 25°C, unless otherwise specified. All values, amounts and measurements described herein are obtained under ambient conditions unless otherwise specified.
  • the deodorant compositions of the present invention can comprise, consist of, or consist essentially of the essential elements and limitations of the invention described herein, as well as any of the additional or optional ingredients, components, or limitations described herein.
  • the method and composition of the present invention are directed to a deodorant composition
  • a deodorant composition comprising a deodorant active, at concentrations ranging from about 0.01% to about 60%, preferably from about 0.01% to about 20%, more preferably from about 0.01% to about 10%), even more preferably from about 0.1% to about 5%, by weight of the composition.
  • Deodorant actives suitable for use in the deodorant compositions of the present invention include any topical material that is known for or is otherwise effective in preventing or eliminating malodor associated with underarm perspiration. These deodorant actives are typically antimicrobial agents (e.g., bactericides, fungicides), malodor-absorbing materials, or combinations thereof.
  • Preferred deodorant actives are antimicrobial agents, non-limiting examples of which include cetyl-trimethylammonium bromide, cetyl pyridinium chloride, benzethonium chloride, diisobutyl phenoxy ethoxy ethyl dimethyl benzyl ammonium chloride, sodium N-lauryl sarcosine, sodium N-palmethyl sarcosine, lauroyl sarcosine, N-myristoyl glycine, potassium N-lauryl sarcosine, trimethyl ammonium chloride, sodium aluminum chlorohydroxy lactate, triethyl citrate, tricetylmethyl ammonium chloride, 2,4,4'-trichloro-2'-hydroxy diphenyl ether (triclosan), 3,4,4'- trichlorocarbanilide (triclocarban), diaminoalkyl amides such as L-lysine hexadecyl amide, heavy metal
  • Preferred deodorant actives are triclosan, triclocarban and combinations thereof, wherein the preferred concentration of either triclosan or triclocarban ranges from about 0.01% to about 1.0%, more preferably from about 0.05% to about 0.5%, even more preferably from about 0.1% to 0.3%, by weight of the composition, and wherein the total concentration of triclosan and triclocarban when used together in a composition ranges from about 0.01% to about 2.0%, more preferably from about 0.2% to about 1.0%, even more preferably from about 0.2% to about 0.6%, by weight of the composition.
  • deodorant actives include odor-absorbing materials such as carbonate and bicarbonate salts, including alkali metal carbonates and bicarbonates, ammonium and tetraalkylammonium. Preferred are sodium and potassium salts of such odor-absorbing materials. Mixtures of deodorant actives are also contemplated and intended to be encompassed herein.
  • compositions of the present invention are directed to a deodorant composition comprising a fragrance or perfume, to impart a desired aroma, to mask odors that may be associated with other components of the compositions, and/or to mask underarm malador.
  • concentration of the fragrance in the composition typically ranges from bout 0.01% to about 10%, preferably from about 1% to about 5%, by weight of the composition.
  • fragment and “perfume” are used interchangably.
  • any fragrance suitable for application to the skin can be used herein including a wide variety of fragrances and perfumes that are known to those skilled in the art.
  • the particular fragrance used is largely a matter of choice; however, the fragrance should be used at a concentration effective for providing a noticeable aroma to the composition, for masking undesired aroma of the composition, and/or to mask underarm malador.
  • the fragrance and whatever carriers accompany it should not impart excessive stinging to the skin, especially broken or irritated skin, at the levels previously disclosed.
  • the fragrance can be water soluble or water insoluble; however it generally will be soluble in the composition hereof, typically in either water or the non-aqueous carrier as described hereafter.
  • Perfumes suitable for use in the deodorant composition of the present invention include the many perfumes having a variety of specific fragrances and strengths, some examples of which are described in Arctander, Perfume and Flavour Chemicals (Aroma Chemicals), Vol. I and II
  • fragrance components as generally including, but are not limited to, volatile phenolic substances (such as iso-amyl salicylate, benzyl salicylate, and thyme oil red); essence oils (such as geranium oil, patchouli oil, and petitgrain oil); citrus oils; extracts and resins (such as benzoin siam resinoid and opoponax resinoid); "synthetic" oils (such as Bergamot 37 and 430, Geranium 76 and Pomeransol 314); aldehydes and ketones (such as B-methyl naphthyl ketone, p-t-butyl-A-methyl hydrocinnamic al
  • Fragrances also include esters and essential oils derived from floral materials and fruits, citrus oils, absolutes, aldehydes, resinoides, musk and other animal notes (e.g., natural isolates of civet, castoreum and musk), balsamic, etc.. and alcohols (such as dimyrcetol, phenylethyl alcohol and tetrahydromuguol).
  • fragrances herein examples include decyl aldehyde, undecyl aldehyde, undecylenic aldehyde, lauric aldehyde, amyl cinnamic aldehyde, ethyl methyl phenyl glycidate, methyl nonyl acetaldehyde, myristic aldehyde, nonalactone, nonyl aldehyde, octyl aldehyde, undecalactone, hexyl cinnamic aldehyde, benzaldehyde, vanillin, heliotropine, para-hydroxy phenolbutanone, 6-acetyl 1,1,3,4,4,6 hexamethyl tetrahydronaphthalene, alpha-methyl ionone, gamma-methyl ionone, and amyl-cyclohexanone and mixtures of these components.
  • the method and compositions of the present invention are directed to a deodorant composition
  • a deodorant composition comprising from about 0.01% to about 15%, by weight, of a soap gelling agent, preferably from about 0.1% to about 10%, more preferably from about 1% to about 8%, most preferably from about 3% to about 7%, wherein the soap gelling agent is a salt of fatty acids containing from about 12 to about 40 carbon atoms (C12-C40), preferably salts of C12-C22 fatty acids, more preferably C14-C20, most preferably C1 g-C20- Suitable salt forming cations for use in these gelling agents include metal salts such as alkali metals, e.g. sodium and potassium, alkaline earth metals, e.g.
  • Non-limiting examples of fatty acids useful in synthesizing the gelling agent include myristic, palmitic, stearic, oleic, linoleic, linolenic, margaric and mixtures of such acids.
  • Naturally occurring sources of such fatty acids include coconut oil, beef tallow, lanolin, fish oil, beeswax, palm oil, peanut oil, olive oil, cottonseed oil, soybean oil, corn oil, rapeseed oil, rosin acids, and greases.
  • Preferred fatty acid soap type gel forming agents include sodium stearate, sodium palmitate, potassium stearate, potassium palmitate, sodium myristate, and aluminum monostearate.
  • the most preferred gel forming agent is sodium stearate.
  • soap gelling agents can also be used.
  • the method and compositions of the present invention are directed to a deodorant composition
  • a deodorant composition comprising a solvent system suitable for topical application to the skin, and which has the components and essential characteristics described hereinafter which solubilize the cooling sensate material within the composition.
  • the solvent system comprises a combination of water and a non-aqueous carrier liquid, wherein the combination has a solubility parameter of from about 9 (cal/cm 3 ) 05 to about 15 (cal/cm 3 ) 05 , preferably from about 10 (cal/cm 3 ) 0,5 to about 14 (cal/cm 3 ) 05 .
  • Solubility parameters as used to characterize the solvent system component of the deodorant composition of the present invention are determined by methods well known in the chemical arts for establishing the relative polar character of a solvent or other material. A description of solubility parameters and means for detennining them are described by CD. Vaughan, "Solubility Effects in Product, Package, Penetration and Preservation” 103 Cosmetics and Toiletries 47-69, October 1988; and C. D. Vaughan, "Using Solubility Parameters in Cosmetics Formulation", 36 J. Soc. Cosmetic Chemists 319-333, September/October, 1988, which descriptions are incorporated herein by reference.
  • the solvent system component of the deodorant composition of the present invention comprises water at concentrations ranging from about 1% to about 90%, preferably from about 10% to about 60%, more preferably from about 15% to about 50%, even more preferably from about 15% to about 30%, by weight of the composition.
  • the solvent system component further comprises a non-aqueous carrier liquid, wherein the addition of the non-aqueous carrier liquid to the selected water component provides the resulting solvent system in the deodorant composition with the solubility parameter as described herein.
  • a non-aqueous carrier liquid that is know for otherwise effective for use on the skin is also suitable for use herein, provided that it is compatible with the essential and any selected optional components in the deodorant composition of the present invention, and provided that it results in the requisite solubility parameter as described herein for the solvent system.
  • the non-aqueous carrier liquid is present in the deodorant composition at a concentration ranging from about 1% to about 90%, preferably from about 30% to about 75, by weight of the deodorant composition.
  • suitable non-aqueous liquid carriers include Ci to C 20 monohydric alcohols, preferably C 2 to C 8 monohydric alcohols; C 2 to C 40 dihydric or polyhydric alcohols, preferably C 2 to C 20 dihydric or polyhydric alcohols; alkyl ethers of all such alcohols (preferably C r C 4 alkyl ethers); and polyalkoxylated glycols such as propylene glycols and polyethylene glycols having from 2 to 30 repeating alkoxylate (e.g., ethoxylate or propoxylate) groups; polyglycerols having from 2 to 16 repeating glycerol moieties; derivatives and combinations thereof.
  • non-aqueous carrier liquids suitable for use herein include propylene glycol; hexylene glycol; dipropylene glycol; tripropylene glycol; tetrapropylene glycol, glycerin; propylene glycol methyl ether; dipropylene glycol methyl ether; ethanol; n- propanol; n-butanol; t-butanol; 2-methoxyethanol; 2-ethoxyethanol; ethylene glycol; isopropanol; isobutanol; 1,4-butylene glycol; 2,3-butylene glycol; trimethylene glycol; 1,3-butanediol, propylene glycol monoisostearate; PPG-3 myristyl ether; PEG-4 (PEG-4 is also known as PEG- 200); PEG-6, PEG-8 (PEG-8 is also known as PEG-400); 1,2, pentanediol; PPG-14 ' butylether
  • PPG-3 myristyl ether propylene glycol, dipropylene glycol, tripropylene glycol, tetrapropylene glycol, PEG-6, PEG-8, hexylene glycol, glycerin, 1,2-hexanediol, 2- methyl-l,3-propanediol (MP Diol) and combinations thereof.
  • non-aqueous carrier liquids for use herein are described in U.S. Patent 4,781,917 (Luebbe et al.), U.S. Patent 5,643,558 (Provancal et al.), U.S. Patent 4,816,261 (Luebbe et al.), EP 404 533 Al (Smith et al), which descriptions are incorporated herein by reference.
  • the method and compositions of the present invention are directed to a deodorant composition
  • a deodorant composition comprising a cooling sensate having a molecular weight of at least 158, and which is solubilized in the selected solvent system described hereinbefore.
  • the concentration of the cooling sensate must range from about 0.10% to about 1%, preferably from about 0.20% to about 0.75%, more preferably from about 0.30% to about 0.60% by weight of the deodorant composition.
  • the cooling sensate for use in the deodorant composition of the present invention can include any sensate material that is known for or otherwise effective in providing a cooling effect on the skin, and which has a minimum molecular weight as described above, preferably a molecular weight ranging from 158 to 290, even more preferably from about 180 to about 250.
  • the cooling sensate must also be capable of being solubilized in the solvent system component of the composition.
  • Nonlimiting examples of cooling sensates suitable for use in the deodorant compositions of the present invention include menthoxypropandiaol or 3-/-Menthoxypropane-l,2-diol, menthyl lactate or Frescolat ML, menthone glycerin acetal or Frescolat MGA, menthyl butanedioc acid or Physcool, n-ethyl mentyl carboxamide (ethyl carboxamide) or WS-3, trimethyl butanamide or WS-23, menthene or Coolact P, eucalyptus oil, carvone and peppermint oil, and combinations thereof. Most preferred is 3-/-Menthoxypropane-l,2-diol.
  • sensates can be added to the deodorant composition, in addition to the cooling sensates described herein, provided that such other sensates are suitable for application to the underarm and are otherwise compatible with the essential and any selected optional ingredients in the deodorant compositions.
  • the deodorant compositions of the present invention is preferably substantially free of such other sensates, more preferably free of menthol and/or camphor, both of which can cause excessive irritation to the skin and/or undesirably affect the fragrance expression of the composition.
  • the terms “free of " and “substantially free of are used interchangeably to mean that the compositions preferably contain less than 0.2%, more preferably less than 0.1%, even more preferably less than 0.05%, most preferably zero percent, of such other sensates by weight of the deodorant composition.
  • compositions of the present invention are directed to a deodorant composition may further comprise one or more other optional materials that are known for use in antiperspirant, deodorant or other personal care product, or which is otherwise suitable for topical application to human skin.
  • Nonlimiting examples of such other optional materials include dyes or colorants, emulsifiers,, distributing agents, pharmaceutical or other topical active, preservatives, surfactants, processing aides such as viscosity modifiers, wash-off aids, pH modifiers, chealants and so forth.
  • the method and compositions of the present invention are directed to a deodorant composition which can be formulated as any known or otherwise effective product form for providing topical application of deodorant active to the desired area of the skin.
  • the deodorant compositions can be in any of a variety of solid, semi-solid or liquid forms, including solid sticks, soft solids such as gels or creams, liquids such as roll-ons or aerosol/nonaerosol sprays, and so forth.
  • the preferred product form is a solid stick, e.g., gel solid.
  • a deodorant composition which may be prepared by any known or otherwise effective technique, suitable for providing a deodorant composition of the desired form and having the essential materials described herein.
  • Many such techniques are described in the deodorant and formulation arts for each of the described product forms, some examples of which are described in U.S. Patents 5,916,546 (Sawin et al.); U.S. Patent 5,902,572 (Luebbe et al); and U.S. Patent 5,585,092 (Trandai et al.), which descriptions are incorporated herein by reference.
  • a deodorant composition of the present invention can be prepared generally by merely combining a liquid carrier with the deodorant active.
  • Optional gellants or structurants may then be added with agitation and hear to a temperature of from about 75 °C to about 100°C to allow the gellant or structurant to melt and form a substantially clear or translucent liquid.
  • the resulting solution is cooled before adding fragrance (if applicable), and then cooled before adding fragrance, and then the cooled composition is poured into an appropriate container or dispenser at about 70°C and allowed to solidify within the container or dispenser by cooling or allowing to cool the contained composition to ambient temperature.
  • compositions of the present invention are directed to a deodorant composition which may be applied topically to the axilla area of the skin in an amount effective to treat or prevent underarm malodor.
  • the composition is preferably applied to each axilla area in an amount ranging from about 0.1 gram to about 20 grams, more preferably from about 0.1 gram to about 10 grams, even more preferably from about 0.1 gram to about 1 gram, to each axilla areato the desired area of the skin.
  • the compositions are preferably applied one or two times daily, more preferably once daily, to achieve effective malodor control over an extended period.
  • each of the exemplified compositions are prepared by methods well known in the formulation art for preparing the various deodorant product forms. All of the exemplified compositions contain solubilized sensate and a solvent system having a solubility parameter of from about 9 (cal/cm ⁇ ) ⁇ - ⁇ to about 15 (cal/c ⁇ )" ⁇ . All exemplified amounts are weight percents based on the total weight of the deodorant composition, unless otherwise specified.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un procédé de traitement ou de prévention de mauvaises odeurs sous les bras par application locale d'une composition désodorisante sous forme de gel aqueuse comprenant: a) d'environ 0,01 % à environ 60 % en poids d'un agent désodorisant actif; b) d'environ 0,01 % à environ 15 % en poids d'un agent gélifiant savonneux renfermant des sels d'acides gras C12-C40; c) d'environ 0,01 % à environ 10 % en poids d'un parfum; d) d'environ 0,2 % à environ 1 % en poids d'un agent sensoriel de la peau solubilisé dans un système de solvants, lequel comprend: I) d'environ 1 % à environ 90 % en poids de la composition d'un support liquide non aqueux; ii) la composition contenant d'environ 1 % à environ 90 % en poids d'eau, ledit système de solvants présentant un paramètre de solubilité allant d'environ 9 (cal/cm3)0,5 à environ 15 (cal/cm3)0,5. L'invention concerne également des procédés d'utilisation desdites compositions. Le procédé et les compositions visent des compositions désodorisantes comprenant un système de solvants spécifique qui assurera une meilleure sensation sur la peau sans occasionner quasiment aucune irritation de la peau et sans interférence ou modification sensible des matrices du parfum de la composition.
PCT/US2001/025223 2000-08-11 2001-08-10 Procede assurant une meilleure application desodorisante sous les bras Ceased WO2002013776A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001283312A AU2001283312A1 (en) 2000-08-11 2001-08-10 Method of providing improved deodorant application to the underarm

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63721700A 2000-08-11 2000-08-11
US09/637,217 2000-08-11

Publications (2)

Publication Number Publication Date
WO2002013776A2 true WO2002013776A2 (fr) 2002-02-21
WO2002013776A3 WO2002013776A3 (fr) 2002-10-03

Family

ID=24555030

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/025223 Ceased WO2002013776A2 (fr) 2000-08-11 2001-08-10 Procede assurant une meilleure application desodorisante sous les bras

Country Status (2)

Country Link
AU (1) AU2001283312A1 (fr)
WO (1) WO2002013776A2 (fr)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1475071A1 (fr) * 2003-05-09 2004-11-10 Basf Aktiengesellschaft Compositions cosmétiques contenant des dérivés de l'acide cyclohexanepolycarboxylique
EP1496095A4 (fr) * 2002-03-01 2005-05-25 Takasago Perfumery Co Ltd Compositions refrigerantes, compositions auxiliaires refrigerantes et leurs utilisations
FR2881951A1 (fr) * 2005-02-11 2006-08-18 Symrise Sa Composition parfumante et composition cosmetique la contenant
WO2007092090A3 (fr) * 2005-12-30 2007-11-15 Dial Corp Compositions antibactériennes liquides contenant du trichlorcarbanilide actif dans une quantité réduite d'eau
FR2923383A1 (fr) * 2007-11-08 2009-05-15 Oreal Utilisation d'un sarcosinate n-acyle comme agent anti-adhesion microbienne.
US7816553B2 (en) 2004-06-21 2010-10-19 Basf Se Cyclohexane polycarboxylic acid derivatives containing adjuvants
EP1833443A4 (fr) * 2005-01-04 2010-11-03 Teikoku Pharma Usa Inc Preparation refrigerante sous forme de timbre topique
WO2010149798A3 (fr) * 2010-06-14 2011-04-14 Symrise Ag Utilisation de polyols pour augmenter l'effet de refroidissement d'une substance refroidissante et mélanges refroidissants ayant un plus grand effet de refroidissement
US20140037571A1 (en) * 2011-03-22 2014-02-06 Givaudan S.A. Malodour counteracting compositions
FR3003753A1 (fr) * 2013-03-29 2014-10-03 Lvmh Rech Composition hydro-alcoolique parfumante contenant un ether aliphatique
US9192559B2 (en) 2006-12-15 2015-11-24 Givaudan Sa Compositions
EP3511026A1 (fr) * 2018-01-12 2019-07-17 GreenAirProducts GmbH Procédé de lutte contre des odeurs nauséabondes
WO2020120748A1 (fr) * 2018-12-13 2020-06-18 Greenairsystems Gmbh Procédé de désodorisation d'air d'échappement
US10722435B2 (en) 2016-06-17 2020-07-28 Conopco, Inc. Deodorant products
CN113271913A (zh) * 2018-12-18 2021-08-17 宝洁公司 具有增加的蒸气释放的个人护理组合物
RU2806435C2 (ru) * 2018-01-12 2023-10-31 Гринэйрсистемз Гмбх Способ борьбы с неприятными запахами
WO2024206744A1 (fr) * 2023-03-31 2024-10-03 Colgate-Palmolive Company Compositions de soins personnels
US12414906B2 (en) 2020-04-10 2025-09-16 The Procter & Gamble Company Compositions and methods for treating hot flashes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1315625A (en) * 1971-02-04 1973-05-02 Wilkinson Sword Ltd P-menthane diols and compositions containing them
GB9005522D0 (en) * 1990-03-12 1990-05-09 Unilever Plc Cosmetic composition
BR9306575A (pt) * 1992-06-17 1998-12-08 Procter & Gamble Composições refrescantes com reduzida ardência
JP2002501544A (ja) * 1997-06-23 2002-01-15 ザ、プロクター、エンド、ギャンブル、カンパニー 減少した皮膚刺激性を有するゲル状防臭組成物
FR2788695B1 (fr) * 1999-01-22 2002-09-06 Roc Sa Composition cosmetique a base de menthol et de menthyl lactate, peu odorante et non-irritante

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1496095A4 (fr) * 2002-03-01 2005-05-25 Takasago Perfumery Co Ltd Compositions refrigerantes, compositions auxiliaires refrigerantes et leurs utilisations
WO2004098547A1 (fr) * 2003-05-09 2004-11-18 Basf Aktiengesellschaft Compositions cosmetiques contenant des derives de l'acide cyclohexane polycarboxylique
EP1475071A1 (fr) * 2003-05-09 2004-11-10 Basf Aktiengesellschaft Compositions cosmétiques contenant des dérivés de l'acide cyclohexanepolycarboxylique
US7816553B2 (en) 2004-06-21 2010-10-19 Basf Se Cyclohexane polycarboxylic acid derivatives containing adjuvants
EP1833443A4 (fr) * 2005-01-04 2010-11-03 Teikoku Pharma Usa Inc Preparation refrigerante sous forme de timbre topique
FR2881951A1 (fr) * 2005-02-11 2006-08-18 Symrise Sa Composition parfumante et composition cosmetique la contenant
US8247454B2 (en) 2005-12-30 2012-08-21 The Dial Corporation Liquid antibacterial compositions incorporating trichlorocarbanilide with reduced water activity
WO2007092090A3 (fr) * 2005-12-30 2007-11-15 Dial Corp Compositions antibactériennes liquides contenant du trichlorcarbanilide actif dans une quantité réduite d'eau
US9192559B2 (en) 2006-12-15 2015-11-24 Givaudan Sa Compositions
WO2009060083A3 (fr) * 2007-11-08 2010-12-23 L'oreal Utilisation d'un sarcosinate n-acylé en tant qu'agent contre l'adhésion microbienne
FR2923383A1 (fr) * 2007-11-08 2009-05-15 Oreal Utilisation d'un sarcosinate n-acyle comme agent anti-adhesion microbienne.
WO2010149798A3 (fr) * 2010-06-14 2011-04-14 Symrise Ag Utilisation de polyols pour augmenter l'effet de refroidissement d'une substance refroidissante et mélanges refroidissants ayant un plus grand effet de refroidissement
US20130202543A1 (en) * 2010-06-14 2013-08-08 Symrise Ag Use of polyols for enhancing the cooling effect of a cooling substance and cooling mixtures having an enhanced cooling effect
US11491091B2 (en) 2010-06-14 2022-11-08 Symrise Ag Cooling product
US20140037571A1 (en) * 2011-03-22 2014-02-06 Givaudan S.A. Malodour counteracting compositions
US10123955B2 (en) 2011-03-22 2018-11-13 Givaudan, S.A. Malodour counteracting compositions
WO2014155019A3 (fr) * 2013-03-29 2015-03-05 Lvmh Recherche Composition alcoolique ou hydro-alcoolique parfumante contenant un ether aliphatique
FR3003753A1 (fr) * 2013-03-29 2014-10-03 Lvmh Rech Composition hydro-alcoolique parfumante contenant un ether aliphatique
US10722435B2 (en) 2016-06-17 2020-07-28 Conopco, Inc. Deodorant products
EP3511026A1 (fr) * 2018-01-12 2019-07-17 GreenAirProducts GmbH Procédé de lutte contre des odeurs nauséabondes
WO2019137770A1 (fr) 2018-01-12 2019-07-18 Greenairproducts Gmbh Procédé de lutte contre les mauvaises odeurs
CN111629764A (zh) * 2018-01-12 2020-09-04 绿色空气系统有限责任公司 控制不良气味的方法
US11583605B2 (en) 2018-01-12 2023-02-21 Greenairsystems Gmbh Method for controlling unpleasant odors
RU2806435C2 (ru) * 2018-01-12 2023-10-31 Гринэйрсистемз Гмбх Способ борьбы с неприятными запахами
WO2020120748A1 (fr) * 2018-12-13 2020-06-18 Greenairsystems Gmbh Procédé de désodorisation d'air d'échappement
CN113271913A (zh) * 2018-12-18 2021-08-17 宝洁公司 具有增加的蒸气释放的个人护理组合物
CN113271913B (zh) * 2018-12-18 2024-04-02 宝洁公司 具有增加的蒸气释放的个人护理组合物
US12414906B2 (en) 2020-04-10 2025-09-16 The Procter & Gamble Company Compositions and methods for treating hot flashes
WO2024206744A1 (fr) * 2023-03-31 2024-10-03 Colgate-Palmolive Company Compositions de soins personnels

Also Published As

Publication number Publication date
AU2001283312A1 (en) 2002-02-25
WO2002013776A3 (fr) 2002-10-03

Similar Documents

Publication Publication Date Title
US5902572A (en) Anhydrous gel deodorant compositions
DE69931909T2 (de) Desodorierende zusammensetzungen die 1,2-hexandiol enthalten
US4759924A (en) Cosmetic sticks
WO2002013776A2 (fr) Procede assurant une meilleure application desodorisante sous les bras
US6126928A (en) Compositions containing solubilized, acid-enhanced antiperspirant active
EP0386900A2 (fr) Compositions désodorisantes contenant des sels spécifiques de piroctone et des parfums
WO2007107966A2 (fr) Compositions a base d'huile de ricin hydrogenee en tant que substituant du petrolatum
US6174521B1 (en) Gel deodorant compositions having reduced skin irritation
CA2229787A1 (fr) Gel cosmetique moins irritant pour la peau
WO1998058625A1 (fr) Compositions desodorisantes sous forme de gel a irritation cutanee reduite
AU7833198A (en) Anhydrous gel deodorant compositions containing volatile nonpolar solvents
EP0024365A2 (fr) Composition gélifiée pour bâton cosmétique
US6096298A (en) Deodorant compositions containing isopropyl glycerol ether
JP2003081801A (ja) 防臭化粧料
ES2924128T3 (es) Productos desodorantes
KR20020031595A (ko) 가용화된 항발한 활성제를 함유하는 조성물
CA2808807A1 (fr) Deodorant a endurance et stabilite ameliorees
MXPA00000073A (en) Anhydrous gel deodorant compositions containing volatile nonpolar solvents
JP2004231580A (ja) 身体用洗浄剤組成物及び洗顔剤
MXPA99011742A (en) Anhydrous gel deodorant compositions
US20200016055A1 (en) Liquor-based underarm deodorant
MXPA99011743A (en) Gel deodorant compositions having reduced skin irritation
MXPA00010755A (en) Deodorant compositions containing 1,2-hexanediol

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP